- Home
- HALO vs DCI Comparison
HALO vs DCI Comparison
Compare HALO & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- DCI
- Stock Information
- Founded
- HALO 1998
- DCI 1915
- Country
- HALO United States
- DCI United States
- Employees
- HALO N/A
- DCI N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- DCI Pollution Control Equipment
- Sector
- HALO Health Care
- DCI Industrials
- Exchange
- HALO Nasdaq
- DCI Nasdaq
- Market Cap
- HALO 7.4B
- DCI 7.9B
- IPO Year
- HALO N/A
- DCI 1987
- Fundamental
- Price
- HALO $49.28
- DCI $70.02
- Analyst Decision
- HALO Buy
- DCI Hold
- Analyst Count
- HALO 9
- DCI 4
- Target Price
- HALO $63.56
- DCI $71.33
- AVG Volume (30 Days)
- HALO 3.0M
- DCI 461.7K
- Earning Date
- HALO 05-06-2025
- DCI 06-03-2025
- Dividend Yield
- HALO N/A
- DCI 1.55%
- EPS Growth
- HALO 55.40
- DCI 11.79
- EPS
- HALO 3.76
- DCI 3.42
- Revenue
- HALO $1,084,306,000.00
- DCI $3,633,400,000.00
- Revenue This Year
- HALO $24.79
- DCI $2.95
- Revenue Next Year
- HALO $22.65
- DCI $3.44
- P/E Ratio
- HALO $13.36
- DCI $20.40
- Revenue Growth
- HALO 25.64
- DCI 4.46
- 52 Week Low
- HALO $41.28
- DCI $57.45
- 52 Week High
- HALO $70.51
- DCI $78.95
- Technical
- Relative Strength Index (RSI)
- HALO 33.34
- DCI 65.12
- Support Level
- HALO $47.50
- DCI $69.63
- Resistance Level
- HALO $69.94
- DCI $70.80
- Average True Range (ATR)
- HALO 3.28
- DCI 0.97
- MACD
- HALO -1.54
- DCI 0.57
- Stochastic Oscillator
- HALO 4.13
- DCI 87.02
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About DCI Donaldson Company Inc.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.